The authors would like to correct an error made through no fault of their own in the title paper [1]. The error is related to the FAR values in Table 1. In the earlier published version, the FAR values of compounds 15–21 were wrongly printed. So, they had to be corrected, from 1.19 to 1.12 for 15, 1.55 to 1.19 for 16, 0.95 to 1.55 for 17, 1.22 to 0.95 for 18, 0.98 to 1.22 for 19, 1.30 to 0.98 for 20 and 0.82 to 1.30 for 21. We provide below the corrected Table 1. The change has no influence on the reported results. The original article has been updated. The authors would like to apologize for any inconvenience caused to the readers by this change.
Table 1.
MRP4 inhibition data of target compounds 4–21 with varied substitution patterns expressed as FAR values.
Reference
- Döring, H.; Kreutzer, D.; Ritter, C.; Hilgeroth, A. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).